The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
Type 2 Diabetes Mellitus
About this trial
This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring diabetes, exenatide, Amylin, Lilly
Eligibility Criteria
Inclusion Criteria: Pre-menopausal female of child-bearing potential. Body Mass Index (BMI) between 19 and 35 kg/m^2, inclusive. Exclusion Criteria: On implanted contraceptives for 6 months, or injectable contraceptives for 12 months prior to the study. Evidence of diabetes mellitus. Participation in a study involving administration of an investigational compound within the past 3 months.
Sites / Locations
- Research Site
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Sequence 1
Sequence 2
Sequence 3
Oral contraceptive 1 hour prior to exenatide/oral contraceptive 30 minutes after exenatide/oral contraceptive alone
Oral contraceptive 30 minutes after exenatide/oral contraceptive alone/oral contraceptive 1 hour prior to exenatide
Oral contraceptive alone/oral contraceptive 1 hour prior to exenatide/oral contraceptive 30 minutes after exenatide